MENU
RNXT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

RenovoRx (RNXT) Earnings Date & Reports

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment... Show more

A.I. Advisor
published Earnings

RNXT is expected to report earnings to rise 6.25% to -8 cents per share on August 14

RenovoRx RNXT Stock Earnings Reports
Q2'25
Est.
$-0.09
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.02
Q2'24
Est.
$-0.10
The last earnings report on May 15 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 194.04K shares outstanding, the current market capitalization sits at 41.69M.
View a ticker or compare two or three
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RNXT showed earnings on May 15, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4546 El Camino Real
Phone
+1 650 284-4433
Employees
8
Web
https://www.renovorx.com